BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 4
• 5
• 6
• 7
• 8
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29

• Press Releases

  PHAXIAM Presented its IVD Phagogram test and updated phage susceptibility tracking at the first “Phagogram Day”

  November 18, 2024

   · 

  5 min read
• Press Releases

  HSS Presents Cutting-Edge Discoveries in Rheumatic Disease and Reproductive Health at ACR Convergence 2024

  November 18, 2024

   · 

  9 min read
• Press Releases

  SetPoint Medical Announces Late-Breaking Data from RESET-RA Study at ACR Convergence 2024

  November 18, 2024

   · 

  5 min read
• Press Releases

  Exo Therapeutics Presents Data on Novel Exosite Inhibitors of TBK1 (EXO-TBKi) Shown to Disrupt Pathological STING-mediated TBK1 Activation at American College of Rheumatology’s Convergence (ACR)

  November 18, 2024

   · 

  4 min read
• Press Releases

  Mallinckrodt Presents Data on TERLIVAZ® (terlipressin) for Injection in Patients with Hepatorenal Syndrome (HRS) at the 2024 American Association for the Study of Liver Diseases (AASLD) Annual Meeting

  November 18, 2024

   · 

  9 min read
• Press Releases

  Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024

  Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the 26-week study Episodes of pericarditis per year substantially reduced MAvERIC-Pilot results support advancing CardiolRx™ into the Phase II/III MAVERIC-2 and the Phase III MAVERIC-3 clinical trials

  November 18, 2024

   · 

  11 min read
• Press Releases

  Children’s Hospital of Philadelphia Researchers Announce Promising Results from First-of-its-Kind, Multicenter, Phase 1 Gene Therapy Trial for Danon Disease

  November 18, 2024

   · 

  4 min read
• Press Releases

  Encora Therapeutics Successfully Completes ULTRE Clinical Trial Evaluating Novel Wrist-Worn Wearable for Essential Tremor

  November 18, 2024

   · 

  2 min read
• Press Releases

  Silence Therapeutics Presents Late-Breaking Phase 2 Zerlasiran Data at 2024 American Heart Association (AHA) Annual Meeting

  November 18, 2024

   · 

  7 min read